ANRO vs MDT · $60.1M cap vs P/E 21, rev $36.36B
Alto Neuroscience, Inc. (ANRO) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Alto Neuroscience, Inc. (ANRO) is a biotechnology company listed on US.
Medtronic PLC (MDT) is a medical devices company listed on US.
ANRO does not have a complete income-statement cache yet.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
ANRO currently screens at market cap $60.1M. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the ANRO and MDT stock pages for the full models.
Not investment advice.